dc.creator | Fonseca A. | |
dc.creator | Matos M.J. | |
dc.creator | Vilar S. | |
dc.creator | Kachler S. | |
dc.creator | Klotz K.-N. | |
dc.creator | Uriarte E. | |
dc.creator | Borges F. | |
dc.date.accessioned | 2020-09-02T22:17:54Z | |
dc.date.accessioned | 2022-11-08T20:23:22Z | |
dc.date.available | 2020-09-02T22:17:54Z | |
dc.date.available | 2022-11-08T20:23:22Z | |
dc.date.created | 2020-09-02T22:17:54Z | |
dc.date.issued | 2018 | |
dc.identifier | 91, 1, 245-256 | |
dc.identifier | 17470277 | |
dc.identifier | https://hdl.handle.net/20.500.12728/4496 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5144806 | |
dc.language | en | |
dc.publisher | Blackwell Publishing Ltd | |
dc.subject | adenosine receptors | |
dc.subject | carboxamidocoumarin | |
dc.subject | coumarins | |
dc.subject | 3 phenylcarboxamidocoumarin derivative | |
dc.subject | adenosine receptor | |
dc.subject | adenylate cyclase | |
dc.subject | coumarin derivative | |
dc.subject | n (2 bromophenyl) 6 methoxycoumarin 3 carboxamide | |
dc.subject | n (2 bromophenyl)coumarin 3 carboxamide | |
dc.subject | n (2 chlorophenyl) 6 methoxycoumarin 3 carboxamide | |
dc.subject | n (2 chlorophenyl) 6 methylcoumarin 3 carboxamide | |
dc.subject | n (2 chlorophenyl)coumarin 3 carboxamide | |
dc.subject | n (2 hydroxyphenyl) 6 methoxycoumarin 3 carboxamide | |
dc.subject | n (2 hydroxyphenyl)coumarin 3 carboxamide | |
dc.subject | n (2 methoxyphenyl) 6 methoxycoumarin 3 carboxamide | |
dc.subject | n (2 methoxyphenyl)coumarin 3 carboxamide | |
dc.subject | n (2 methylphenyl) 6 methoxycoumarin 3 carboxamide | |
dc.subject | n (2 methylphenyl)coumarin 3 carboxamide | |
dc.subject | n (3 bromophenyl) 6 methoxycoumarin 3 carboxamide | |
dc.subject | n (3 bromophenyl)coumarin 3 carboxamide | |
dc.subject | n (3 chlorophenyl) 6 methoxycoumarin 3 carboxamide | |
dc.subject | n (3 chlorophenyl) 6 methylcoumarin 3 carboxamide | |
dc.subject | n (3 chlorophenyl)coumarin 3 carboxamide | |
dc.subject | n (3 hydroxyphenyl) 6 methoxycoumarin 3 carboxamide | |
dc.subject | n (3 hydroxyphenyl)coumarin 3 carboxamide | |
dc.subject | n (3 methoxyphenyl) 6 methoxycoumarin 3 carboxamide | |
dc.subject | n (3 methoxyphenyl)coumarin 3 carboxamide | |
dc.subject | n (3 methylphenyl) 6 methoxycoumarin 3 carboxamide | |
dc.subject | n (3 methylphenyl)coumarin 3 carboxamide | |
dc.subject | n (4 hydroxyphenyl) 6 methoxycoumarin 3 carboxamide | |
dc.subject | n (4 hydroxyphenyl)coumarin 3 carboxamide | |
dc.subject | n (4 methylphenyl)coumarin 3 carboxamide | |
dc.subject | unclassified drug | |
dc.subject | unindexed drug | |
dc.subject | adenosine receptor | |
dc.subject | coumarin derivative | |
dc.subject | isoprotein | |
dc.subject | ligand | |
dc.subject | Article | |
dc.subject | binding affinity | |
dc.subject | drug receptor binding | |
dc.subject | drug structure | |
dc.subject | drug synthesis | |
dc.subject | human | |
dc.subject | molecular docking | |
dc.subject | molecular model | |
dc.subject | priority journal | |
dc.subject | process optimization | |
dc.subject | structure analysis | |
dc.subject | binding site | |
dc.subject | chemistry | |
dc.subject | drug design | |
dc.subject | metabolism | |
dc.subject | protein tertiary structure | |
dc.subject | radioassay | |
dc.subject | structure activity relation | |
dc.subject | Binding Sites | |
dc.subject | Coumarins | |
dc.subject | Drug Design | |
dc.subject | Humans | |
dc.subject | Ligands | |
dc.subject | Molecular Docking Simulation | |
dc.subject | Protein Isoforms | |
dc.subject | Protein Structure, Tertiary | |
dc.subject | Radioligand Assay | |
dc.subject | Receptors, Purinergic P1 | |
dc.subject | Structure-Activity Relationship | |
dc.title | Coumarins and adenosine receptors: New perceptions in structure–affinity relationships | |
dc.type | Article | |